Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04888533 · ClinicalTrials.gov registry record
Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool (EHSSA) - Very Accurate Prediction of Risk.
A clinical trial of Suicide Risk, sponsored by Care Plus NJ.
- Completed
- Registry status
- 1,505
- Enrollment target
- 1
- Study location
NCT04888533: Completed study of Suicide Risk, sponsored by Care Plus NJ.
NCT04888533 is a study of Suicide Risk that has completed, run by Care Plus NJ. The registered enrollment target is 1,505 participants, above the 768-participant average among 4 other Suicide Risk trials with a reported enrollment target (96% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04888533, a study of Suicide Risk, has completed, sponsored by Care Plus NJ.
- COMPLETED
- Registry status
- 1,505 participants
- Enrollment target
- 1
- Study location
Study Summary
Many studies have found that insights regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals. E.H.S.S.A. - a suicide assessment tool that was empirically designed by an emergency psychiatry department (P.E.S.P. of Bergen County) in its effort to accurately predict, in specific patients, the risk of suicide attempts in the reasonably foreseeable future. It is of a unique paradigm that combines critical elements of holism, heuristics and semi-structured design.
Primary Outcome
Reported/ascertained cases among the cohort of completed or serious suicide attempts within 15 days of EHSSA evaluation and discharge to community or until the start of treatment with an outpatient mental health professional, whichever came sooner.
Conditions Studied
Interventions
- OTHER EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment Tool
Study Locations (1)
New Jersey
- Care Plus NJ, Inc.- PESP (Psychiatric Emergency Screening Program) - Paramus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,505 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2020-01-31 |
What the finished NCT04888533 record still lists
NCT04888533 is an observational study that tracks outcomes without assigning an intervention. Its 1,505 participants enrollment target places it among the larger protocols in the corpus, above the 768-participant average among 4 other Suicide Risk trials with a reported enrollment target (96% higher).
The record links to 1 condition, with Suicide Risk appearing as the primary indexed condition, and to 1 intervention - of which EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment Tool is the first listed.
NCT04888533 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04888533 about?
NCT04888533 is a clinical study titled "Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool (EHSSA) - Very Accurate Prediction of Risk.". Many studies have found that insights regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals. E.H.S.S.A. - a suicide assessment tool that was empirically designed by an emergency psychiatry department (P.E.S.P. of ...
What is the current status of trial NCT04888533?
This trial is currently completed. The enrollment target is 1,505 participants. The study started on 2019-08-01. Estimated completion is 2020-01-31.
What conditions does trial NCT04888533 study?
This clinical trial studies the following conditions: Suicide Risk.
What interventions are being tested in trial NCT04888533?
The interventions under investigation include: EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment Tool (OTHER).
Who is sponsoring clinical trial NCT04888533?
This trial is sponsored by Care Plus NJ, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04888533 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment for Individuals Interacting with the Criminal Justice System
RECRUITING · NA
-
Long-term Observation of Participants With Mood Disorders
RECRUITING
-
Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial
RECRUITING · Phase 2
-
Get Better Together: Relationship Education For Military Couples
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI